{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:04:52Z","timestamp":1793124292945,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015317","name":"Translational Research Institute, University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","award":["UL1 TR003107"],"award-info":[{"award-number":["UL1 TR003107"]}],"id":[{"id":"10.13039\/100015317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5T32 DA022981-14"],"award-info":[{"award-number":["5T32 DA022981-14"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.drugalcdep.2024.112463","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T16:29:01Z","timestamp":1729787341000},"page":"112463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid na\u00efve patients"],"prefix":"10.1016","volume":"265","author":[{"given":"Allen M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2024.112463_bib1","unstructured":"Agency for healthcare research and quality. (2022). AHRQ Quality Indicators. \u3008https:\/\/qualityindicators.ahrq.gov\/resources\/toolkits\u3009"},{"issue":"8","key":"10.1016\/j.drugalcdep.2024.112463_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272142","article-title":"Trends in opioid and non-opioid treatment for chronic non-cancer pain and cancer pain among privately insured adults in the United States, 2012\u20132019","volume":"17","author":"Bandara","year":"2022","journal-title":"PLOS ONE"},{"issue":"16","key":"10.1016\/j.drugalcdep.2024.112463_bib3","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s11606-022-07807-8","article-title":"Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers","volume":"37","author":"Barrett","year":"2022","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.112463_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/add.14867","article-title":"Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014","volume":"115","author":"Burke","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib5","unstructured":"CADCA. (2016). Comprehensive Addiction and Recovery Act (CARA). \u3008https:\/\/www.cadca.org\/comprehensive-addiction-and-recovery-act-cara\u3009"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib6","unstructured":"Centers for disease control and prevention. (2015). International Classification of Diseases, (ICD-10-CM\/PCS) Transition - Background. \u3008Https:\/\/Www.Cdc.Gov\/Nchs\/Icd\/Icd10cm_pcs_background.Htm\u3009. \u3008https:\/\/www.cdc.gov\/nchs\/icd\/icd10cm_pcs_background.htm\u3009"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib7","unstructured":"Centers for disease control and prevention. (2021). U.S. Opioid Dispensing Rate Maps. \u3008https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html\u3009"},{"issue":"2","key":"10.1016\/j.drugalcdep.2024.112463_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ALN.0000000000002771","article-title":"Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty","volume":"131","author":"Chen","year":"2019","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.112463_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The Effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.112463_bib10","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s11606-019-05150-z","article-title":"Impact of state laws restricting opioid duration on characteristics of new opioid prescriptions","volume":"34","author":"Dave","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain \u2014 United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"Mmwr. Recomm. Rep."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.112463_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"Mmwr. Recomm. Rep."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib13","unstructured":"Federal Register. (2020). Medicaid Program | Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. \u3008https:\/\/www.federalregister.gov\/documents\/2020\/12\/31\/2020-28567\/medicaid-program-establishing-minimum-standards-in-medicaid-state-drug-utilization-review-dur-and\u3009"},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.112463_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.annemergmed.2019.08.446","article-title":"Opioid use during the six months after an emergency department visit for acute pain: a prospective cohort study","volume":"75","author":"Friedman","year":"2020","journal-title":"Ann. Emerg. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.112463_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PHH.0000000000001149","article-title":"Opioid-prescribing metrics in washington state: trends and challenges","volume":"26","author":"Fulton-Kehoe","year":"2020","journal-title":"J. Public Health Manag. Pract."},{"issue":"7","key":"10.1016\/j.drugalcdep.2024.112463_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpsychires.2020.08.014","article-title":"Trends in anxiety among adults in the United States, 2008\u20132018: Rapid increases among young adults","volume":"130","author":"Goodwin","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.112463_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.amepre.2022.05.014","article-title":"Trends in U.S. Depression prevalence from 2015 to 2020: the widening treatment gap","volume":"63","author":"Goodwin","year":"2022","journal-title":"Am. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1186\/s12889-023-16256-9","article-title":"Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities","volume":"23","author":"Gunadi","year":"2023","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.112463_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s11606-017-4283-8","article-title":"Decline in Prescription Opioids Attributable to Decreases in Long-Term Use: A Retrospective Study in the Veterans Health Administration 2010\u20132016","volume":"33","author":"Hadlandsmyth","year":"2018","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.japh.2018.09.005","article-title":"Associations between initial opioid exposure and the likelihood for long-term use","volume":"59","author":"Hadlandsmyth","year":"2019","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib22","unstructured":"IQVIA. (2022). IQVIA PharMetrics\u00ae Plus. \u3008https:\/\/www.iqvia.com\/library\/fact-sheets\/iqvia-pharmetrics-plus\u3009"},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.112463_bib23","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/pm\/pnaa313","article-title":"Oral Opioid Prescribing Trends in the United States, 2002\u20132018","volume":"21","author":"Kern","year":"2020","journal-title":"Pain. Med."},{"issue":"9","key":"10.1016\/j.drugalcdep.2024.112463_bib24","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.arth.2022.04.007","article-title":"Efficacy and Durability of Opioid Restrictive State Legislation Two Years After Implementation for Total Knee Arthroplasty","volume":"37","author":"Kraekel","year":"2022","journal-title":"J. Arthroplast."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2024.112463_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","article-title":"Trends in opioid analgesic\u2013prescribing rates by specialty, U.S., 2007\u20132012","volume":"49","author":"Levy","year":"2015","journal-title":"Am. J. Prev. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.112463_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans","volume":"158","author":"Lin","year":"2017","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2004.06.006","article-title":"Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence","volume":"79","author":"Liu","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109727","article-title":"Intended and unintended consequences: Changes in opioid prescribing practices for postsurgical, acute, and chronic pain indications following two policies in North Carolina, 2012\u20132018 \u2013 Controlled and single-series interrupted time series analyses","volume":"242","author":"Maierhofer","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib30","unstructured":"McClure, D., Mitra-Majumdar, M., & Fass, J. (n.d.). Rethinking the Opioid Crisis. 2018. Retrieved 9 May 2022, from \u3008https:\/\/www.urban.org\/research\/publication\/rethinking-opioid-crisis\u3009."},{"issue":"4","key":"10.1016\/j.drugalcdep.2024.112463_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11606-022-07796-8","article-title":"Effects of opioid prescribing cap laws on opioid and other pain treatments among persons with chronic pain","volume":"38","author":"McCourt","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2017.07.016","article-title":"Long-term morphine delivery via slow release morphine pellets or osmotic pumps: plasma concentration, analgesia, and naloxone-precipitated withdrawal","volume":"185","author":"McLane","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib33","unstructured":"National Conference of State Legislatures. (2019). Prescribing policies: states confront opioid overdose epidemic. \u3008Https:\/\/Www.Ncsl.Org\/Research\/Health\/Prescribing-Policies-States-Confront-Opioid-Overdose-Epidemic.Aspx\u3009."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib34","unstructured":"National Institute on Drug Abuse. (2024). Overdose Death Rates. \u3008https:\/\/nida.nih.gov\/drug-topics\/trends-statistics\/overdose-death-rates\u3009"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib35","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation","author":"Oliva","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.drugalcdep.2024.112463_bib36","first-page":"779","article-title":"Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida\u2019s acute pain opioid restriction law","volume":"27","author":"Oueini","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"8","key":"10.1016\/j.drugalcdep.2024.112463_bib37","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1016\/j.arth.2021.03.055","article-title":"Florida State Opioid Prescription Restriction Law: Impact on Opioid Utilization After Total Joint Arthroplasty","volume":"36","author":"Pannu","year":"2021","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib38","unstructured":"Prescrire International. (2016). \u201cWeak\u201d opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine. Prescrire International, 25(168), 45\u201350."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib39","volume":"2021","author":"Romero","year":"2021","journal-title":"R46805 Consum. Prescr. Opioids Pain: A Comp. Opioid Use U. S. Other Ctries."},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.112463_bib40","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/pm\/pnac068","article-title":"Changes in Opioid Dispensing by Medical Specialties After the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain","volume":"23","author":"Salvatore","year":"2022","journal-title":"Pain. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2024.112463_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/1475-6773.14023","article-title":"Effects of state opioid prescribing cap laws on opioid prescribing after surgery","volume":"57","author":"Schmid","year":"2022","journal-title":"Health Serv. Res."},{"issue":"9","key":"10.1016\/j.drugalcdep.2024.112463_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2012.234","article-title":"Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan","volume":"307","author":"Seal","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13011-021-00349-y","article-title":"Assessing the impact of a restrictive opioid prescribing law in West Virginia","volume":"16","author":"Sedney","year":"2021","journal-title":"Subst. Abus. Treat., Prev., Policy"},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.112463_bib44","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jpain.2017.06.010","article-title":"Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies","volume":"18","author":"Shah","year":"2017","journal-title":"J. Pain."},{"issue":"10","key":"10.1016\/j.drugalcdep.2024.112463_bib45","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use \u2014 United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109232","article-title":"The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic","volume":"231","author":"Stein","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib47","article-title":"Trends in co-prescribed opioids and benzodiazepines, non-prescribed opioids and benzodiazepines, and schedule-I drugs in the United States, 2013 to 2019","volume":"38","author":"Taha","year":"2024","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib48","unstructured":"Therapeutic Goods Administration. (2018). Prescription strong (Schedule 8) opioid use and misuse in Australia \u2013 options for a regulatory response: consultation paper. \u3008https:\/\/apo.org.au\/node\/128606\u3009"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109626","article-title":"State prescribing cap laws\u2019 association with opioid analgesic prescribing and opioid overdose","volume":"240","author":"Tormohlen","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107535","article-title":"Effects of state opioid prescribing cap laws on providers\u2019 opioid prescribing patterns among patients with chronic non-cancer pain","volume":"172","author":"Tormohlen","year":"2023","journal-title":"Prev. Med."},{"key":"10.1016\/j.drugalcdep.2024.112463_bib51","unstructured":"U.S. Department of Veterans Affairs. (2022). VHA Pain Management. \u3008https:\/\/www.va.gov\/painmanagement\/opioid_safety_initiative_osi.asp\u3009"},{"key":"10.1016\/j.drugalcdep.2024.112463_bib52","unstructured":"US Department of Health and Human Services. (2020). Substance use disorder prevention that promotes opioid recovery and treatment for patients and communities (SUPPORT) Act section 7024: report to congress on opioid prescribing limits (132 STAT. 3894). \u3008https:\/\/www.congress.gov\/115\/plaws\/publ271\/PLAW-115publ271.pdf\u3009. \u3008https:\/\/www.congress.gov\/115\/plaws\/publ271\/PLAW-115publ271.pdf\u3009"},{"issue":"8","key":"10.1016\/j.drugalcdep.2024.112463_bib53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1007\/s11606-021-06966-4","article-title":"Changes in Prescribing by Provider Type Following a State Prescription Opioid Restriction Law","volume":"37","author":"Valdes","year":"2022","journal-title":"J. Gen. Intern. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2024.112463_bib54","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11999.0000000000000292","article-title":"The 2018 Chitranjan S. Ranawat, MD Award: Developing and Implementing a Novel Institutional Guideline Strategy Reduced Postoperative Opioid Prescribing After TKA and THA","volume":"477","author":"Wyles","year":"2019","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"8","key":"10.1016\/j.drugalcdep.2024.112463_bib55","first-page":"1095","article-title":"A comparison between accelerated failure-time and cox proportional hazard models in analyzing the survival of gastric cancer patients","volume":"44","author":"Zare","year":"2015","journal-title":"Iran. J. Public Health"},{"issue":"11","key":"10.1016\/j.drugalcdep.2024.112463_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMsa1807069","article-title":"Initial Opioid prescriptions among U.S. commercially insured patients, 2012\u20132017","volume":"380","author":"Zhu","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871624013887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871624013887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:15:12Z","timestamp":1737000912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871624013887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":56,"alternative-id":["S0376871624013887"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.112463","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid na\u00efve patients","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2024.112463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112463"}}